AGÕæÈ˹ٷ½

STOCK TITAN

HealthStream Announces First Quarter 2025 Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

NASHVILLE, Tenn.--(BUSINESS WIRE)-- HealthStream, Inc. (the "Company") (Nasdaq: HSTM), a leading healthcare technology platform for workforce solutions, announced today results for the first quarter ended March 31, 2025.

First Quarter 2025

  • Revenues of $73.5 million in the first quarter of 2025, up 1.0% from $72.8 million in the first quarter of 2024
  • Operating income of $4.4 million in the first quarter of 2025, down 23.1% from $5.7 million in the first quarter of 2024
  • Net income of $4.3 million in the first quarter of 2025, down 17.1% from $5.2 million in the first quarter of 2024
  • Earnings per share (EPS) of $0.14 per share (diluted) in the first quarter of 2025, down from $0.17 per share (diluted) in the first quarter of 2024
  • Adjusted EBITDA1 of $16.2 million in the first quarter of 2025, down 5.0% from $17.1 million in the first quarter of 2024
  • Board of Directors declared a quarterly cash dividend of $0.031 per share, payable on May 30, 2025 to holders of record on May 19, 2025
  • On March 7, 2025, Charles E. Beard, Jr. joined the Company's Board of Directors

1 Adjusted EBITDA is a non-GAAP financial measure. A reconciliation of adjusted EBITDA to net income and disclosure regarding why we believe adjusted EBITDA provides useful information to investors is included later in this release.

Financial Results:

First Quarter 2025 Compared to First Quarter 2024

Revenues for the first quarter of 2025 increased by $0.7 million, or 1.0%, to $73.5 million, compared to $72.8 million for the first quarter of 2024. Subscription revenues increased by $0.6 million, or 0.8%, and professional services revenues increased by $0.1 million compared to the first quarter of 2024. Compared to the first quarter of 2024, revenue growth for the first quarter of 2025 was negatively impacted by several factors, including a $1.7 million reduction from attrition in legacy applications, a $0.9 million reduction in perpetual license sales, and a $0.6 million reduction from customer bankruptcies. These reductions to revenue were more than offset by $3.9 million of revenue growth across our portfolio of solutions.

Operating income was $4.4 million for the first quarter of 2025, down 23.1% from $5.7 million in the first quarter of 2024. Over the past year, we have continued to make investments in several areas of the business, primarily in our platform and SaaS applications, resulting in higher labor costs, cloud hosting, third-party software, and amortization of capitalized software, as well increased costs associated with our sales and marketing efforts. The increased investments along with the changes in our revenue mix, specifically the lost revenues from legacy applications, contributed to the decline in operating income.

Net income was $4.3 million in the first quarter of 2025, down 17.1% from $5.2 million in the first quarter of 2024, and EPS was $0.14 per share (diluted) in the first quarter of 2025, down from $0.17 per share (diluted) in the first quarter of 2024.

Adjusted EBITDA was $16.2 million for the first quarter of 2025, down 5.0% from $17.1 million in the first quarter of 2024.

At March 31, 2025, the Company had cash, cash equivalents, and marketable securities of $113.3 million. The Company does not have any outstanding indebtedness for borrowed money. Capital expenditures incurred during the first quarter of 2025 were $7.9 million.

Other Business Updates

On May 5, 2025, the Board approved a quarterly cash dividend under the Company's dividend policy of $0.031 per share, payable on May 30, 2025 to holders of record on May 19, 2025.

On March 13, 2025, the Company announced that it had signed an agreement to sublease the 9th and 10th floor space in the Capitol View building in Nashville, Tennessee. The sublease commenced in April 2025 and will end in the fourth quarter of 2031.

Addition to Board of Directors

On March 7, 2025, the Board of Directors appointed Charles E. Beard, Jr. as a member of the Company’s Board. Mr. Beard brings a wealth of experience from his more than 30-year career, where he has held several executive-level positions. Until his retirement in December 2024, he served as Chief Operating Officer at Guidehouse, a global consultancy. Prior to that position, he was a Partner at PwC, working with counsel on investigations of transnational computer-based financial crimes affecting corporate earnings, compliance programs, intellectual property protection, and technology risks. He also previously served as the Chief Information Officer for SAIC (now Leidos) and General Manager of its cybersecurity unit.

Financial Outlook for 2025

The Company is updating its guidance for 2025 for certain of the measures set forth below. For a reconciliation of projected adjusted EBITDA, a non-GAAP financial measure defined later in this release, to projected net income (the most comparable GAAP measure) for 2025, see the table included on page eight of this release.

Ìý

Ìý

Full Year 2025 Guidance

Ìý

Ìý

Ìý

Low

Ìý

Ìý

Ìý

Ìý

High

Ìý

Ìý

Revenue1

Ìý

$

297.5

Ìý

-

Ìý

$

303.5

Ìý

million

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Net Income2

Ìý

$

18.6

Ìý

-

Ìý

$

21.0

Ìý

million

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Adjusted EBITDA3

Ìý

$

68.5

Ìý

-

Ìý

$

72.5

Ìý

million

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Capital Expenditures

Ìý

$

31.0

Ìý

-

Ìý

$

34.0

Ìý

million

1 Previous expected Revenue guidance range was $302.0 to $307.0 million.

2 Previous expected Net Income guidance range was $19.2 to $21.4 million.

3 Previous expected Adjusted EBITDA guidance range was $70.0 to $74.0 million.

The Company’s guidance for 2025, as set forth above, reflects the Company’s assumptions regarding, among other things, expectations for new sales and renewals. This consolidated guidance does not include the impact of any acquisitions or dispositions that we may complete during 2025, gains or losses from changes in the fair value of non-marketable equity investments, or impairment of long-lived assets. A factor in the Company’s update to guidance for 2025 relates to current macroeconomic conditions impacting some of our healthcare organization customers. The Company’s updated guidance does not reflect the potential occurrence of unpredictable events, such as significant reductions to payment rates or insurance coverage for individuals.

Commenting on HealthStream’s results, Robert A. Frist, Jr., Chief Executive Officer, HealthStream, said, “On a year-over-year basis, we expect to deliver growth in both revenue and adjusted EBITDA. Due to recent issues of technology scaling with CredentialStream, which have been addressed but are impacting the year, and macroeconomic conditions affecting renewals and purchasing patterns for some elective content, we are trimming our financial outlook for the year. Our bookings and sales pipelines remain strong. In fact, we signed one of the largest customer contracts in the history of our Company during the first quarter. I look forward to reporting to you on our progress next quarter and thereafter.�

A conference call with Robert A. Frist, Jr., Chief Executive Officer, Scott A. Roberts, Chief Financial Officer and Senior Vice President, and Mollie Condra, Head, Investor Relations and Communications, will be held on Tuesday, May 6, 2025, at 9:00 a.m. (ET). Participants may access the conference call live via webcast using this link: .To participate via telephone, please register in advance using this link: . A replay of the conference call and webcast will be archived on the Company’s website in the Investor Relations section under “Events & Presentations.�

Use of Non-GAAP Financial Measures

This press release presents adjusted EBITDA, a non-GAAP financial measure used by management in analyzing the Company’s financial results and ongoing operational performance. In order to better assess the Company’s financial results, management believes that net income before interest, income taxes, stock-based compensation, depreciation and amortization, and changes in fair value of, including gains (losses) on the sale of, non-marketable equity investments (“adjusted EBITDA�) is a useful measure for evaluating the operating performance of the Company because adjusted EBITDA reflects net income adjusted for certain GAAP accounting, non-cash, and/or non-operating items which may not, in any such case, fully reflect the underlying operating performance of our business. We believe that adjusted EBITDA is useful to investors to assess the Company’s ongoing operating performance and to compare the Company’s operating performance between periods. In addition, certain short-term cash incentive bonuses and performance-based equity awards are based on the achievement of adjusted EBITDA (as defined in applicable bonus and equity grant documentation) targets.

Adjusted EBITDA is a non-GAAP financial measure and should not be considered as a measure of financial performance under GAAP. Because adjusted EBITDA is not a measurement determined in accordance with GAAP, adjusted EBITDA is susceptible to varying calculations. Accordingly, adjusted EBITDA, as presented, may not be comparable to other similarly titled measures of other companies and has limitations as an analytical tool.

This non-GAAP financial measure should not be considered a substitute for, or superior to, measures of financial performance, which are prepared in accordance with GAAP. Investors are encouraged to review the reconciliations of adjusted EBITDA to net income (the most comparable GAAP measure), which is set forth below in this release.

About HealthStream

HealthStream (Nasdaq: HSTM) is the healthcare industry’s largest ecosystem of platform-delivered workforce solutions that empowers healthcare professionals to do what they do best: deliver excellence in patient care. For more information about HealthStream, visit or call 615-301-3100.

HEALTHSTREAM, INC.

Condensed Consolidated Statements of Income

(In thousands, except per share data)

(Unaudited)

Ìý

Ìý

Ìý

Three Months Ended

Ìý

Ìý

Ìý

March 31, 2025

Ìý

Ìý

March 31, 2024

Ìý

Revenues, net

Ìý

$

73,485

Ìý

Ìý

$

72,760

Ìý

Operating costs and expenses:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Cost of revenues (excluding depreciation and amortization)

Ìý

Ìý

25,487

Ìý

Ìý

Ìý

24,617

Ìý

Product development

Ìý

Ìý

12,047

Ìý

Ìý

Ìý

12,032

Ìý

Sales and marketing

Ìý

Ìý

12,149

Ìý

Ìý

Ìý

11,773

Ìý

General and administrative

Ìý

Ìý

8,669

Ìý

Ìý

Ìý

8,312

Ìý

Depreciation and amortization

Ìý

Ìý

10,755

Ìý

Ìý

Ìý

10,336

Ìý

Total operating costs and expenses

Ìý

Ìý

69,107

Ìý

Ìý

Ìý

67,070

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Operating income

Ìý

Ìý

4,378

Ìý

Ìý

Ìý

5,690

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Other income, net

Ìý

Ìý

870

Ìý

Ìý

Ìý

853

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Income before income tax provision

Ìý

Ìý

5,248

Ìý

Ìý

Ìý

6,543

Ìý

Income tax provision

Ìý

Ìý

916

Ìý

Ìý

Ìý

1,316

Ìý

Net income

Ìý

$

4,332

Ìý

Ìý

$

5,227

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Net income per share:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Basic

Ìý

$

0.14

Ìý

Ìý

$

0.17

Ìý

Diluted

Ìý

$

0.14

Ìý

Ìý

$

0.17

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Weighted average shares of common stock outstanding:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Basic

Ìý

Ìý

30,444

Ìý

Ìý

Ìý

30,313

Ìý

Diluted

Ìý

Ìý

30,587

Ìý

Ìý

Ìý

30,418

Ìý

Dividends declared per share

Ìý

$

0.031

Ìý

Ìý

$

0.028

Ìý

HEALTHSTREAM, INC.

Condensed Consolidated Balance Sheets

(In thousands)

(Unaudited)

Ìý

Ìý

Ìý

March 31,

Ìý

Ìý

December 31,

Ìý

Ìý

Ìý

2025

Ìý

Ìý

2024

Ìý

ASSETS

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Current assets:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Cash and cash equivalents

Ìý

$

77,289

Ìý

Ìý

$

59,469

Ìý

Marketable securities

Ìý

Ìý

36,030

Ìý

Ìý

Ìý

37,748

Ìý

Accounts and unbilled receivables, net

Ìý

Ìý

36,087

Ìý

Ìý

Ìý

35,322

Ìý

Prepaid and other current assets

Ìý

Ìý

20,312

Ìý

Ìý

Ìý

20,583

Ìý

Total current assets

Ìý

Ìý

169,718

Ìý

Ìý

Ìý

153,122

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Capitalized software development, net

Ìý

Ìý

44,042

Ìý

Ìý

Ìý

43,370

Ìý

Property and equipment, net

Ìý

Ìý

10,696

Ìý

Ìý

Ìý

10,741

Ìý

Operating lease right of use assets, net

Ìý

Ìý

16,846

Ìý

Ìý

Ìý

17,453

Ìý

Goodwill and intangible assets, net

Ìý

Ìý

243,361

Ìý

Ìý

Ìý

246,768

Ìý

Other assets

Ìý

Ìý

39,373

Ìý

Ìý

Ìý

39,312

Ìý

Total assets

Ìý

$

524,036

Ìý

Ìý

$

510,766

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

LIABILITIES AND SHAREHOLDERS� EQUITY

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Current liabilities:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Accounts payable, accrued, and other liabilities

Ìý

$

23,852

Ìý

Ìý

$

31,466

Ìý

Deferred revenue

Ìý

Ìý

102,009

Ìý

Ìý

Ìý

84,227

Ìý

Total current liabilities

Ìý

Ìý

125,861

Ìý

Ìý

Ìý

115,693

Ìý

Deferred tax liabilities

Ìý

Ìý

15,352

Ìý

Ìý

Ìý

14,596

Ìý

Deferred revenue, noncurrent

Ìý

Ìý

1,330

Ìý

Ìý

Ìý

1,655

Ìý

Operating lease liability, noncurrent

Ìý

Ìý

16,640

Ìý

Ìý

Ìý

17,366

Ìý

Other long-term liabilities

Ìý

Ìý

2,045

Ìý

Ìý

Ìý

2,101

Ìý

Total liabilities

Ìý

Ìý

161,228

Ìý

Ìý

Ìý

151,411

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Shareholders� equity:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Common stock

Ìý

Ìý

252,466

Ìý

Ìý

Ìý

252,432

Ìý

Accumulated other comprehensive loss

Ìý

Ìý

(2,019

)

Ìý

Ìý

(2,049

)

Retained earnings

Ìý

Ìý

112,361

Ìý

Ìý

Ìý

108,972

Ìý

Total shareholders� equity

Ìý

Ìý

362,808

Ìý

Ìý

Ìý

359,355

Ìý

Total liabilities and shareholders' equity

Ìý

$

524,036

Ìý

Ìý

$

510,766

Ìý

HEALTHSTREAM, INC.

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

Ìý

Ìý

Ìý

Three Months Ended

Ìý

Ìý

Ìý

March 31,

Ìý

Ìý

March 31,

Ìý

Ìý

Ìý

2025

Ìý

Ìý

2024

Ìý

Operating activities:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Net income

Ìý

$

4,332

Ìý

Ìý

$

5,227

Ìý

Adjustments to reconcile net income to net cash provided by operating activities:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Depreciation and amortization

Ìý

Ìý

10,755

Ìý

Ìý

Ìý

10,336

Ìý

Stock-based compensation

Ìý

Ìý

1,104

Ìý

Ìý

Ìý

1,060

Ìý

Amortization of deferred commissions

Ìý

Ìý

3,150

Ìý

Ìý

Ìý

2,957

Ìý

Deferred income taxes

Ìý

Ìý

751

Ìý

Ìý

Ìý

771

Ìý

Provision for credit losses

Ìý

Ìý

237

Ìý

Ìý

Ìý

174

Ìý

Loss on equity method investments

Ìý

Ìý

72

Ìý

Ìý

Ìý

31

Ìý

Other

Ìý

Ìý

(399

)

Ìý

Ìý

(346

)

Changes in assets and liabilities:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Accounts and unbilled receivables

Ìý

Ìý

(1,001

)

Ìý

Ìý

(5,782

)

Prepaid and other assets

Ìý

Ìý

(2,513

)

Ìý

Ìý

(1,783

)

Accounts payable, accrued, and other liabilities

Ìý

Ìý

(6,871

)

Ìý

Ìý

(6,259

)

Deferred revenue

Ìý

Ìý

17,457

Ìý

Ìý

Ìý

14,552

Ìý

Net cash provided by operating activities

Ìý

Ìý

27,074

Ìý

Ìý

Ìý

20,938

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Investing activities:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Proceeds (purchases) of marketable securities, net of proceeds

Ìý

Ìý

2,097

Ìý

Ìý

Ìý

(124

)

Proceeds from sale of non-marketable equity investments

Ìý

Ìý

�

Ìý

Ìý

Ìý

765

Ìý

Purchase of other investments

Ìý

Ìý

(500

)

Ìý

Ìý

�

Ìý

Purchases of property and equipment

Ìý

Ìý

(1,055

)

Ìý

Ìý

(742

)

Payments associated with capitalized software development

Ìý

Ìý

(7,790

)

Ìý

Ìý

(7,019

)

Net cash used in investing activities

Ìý

Ìý

(7,248

)

Ìý

Ìý

(7,120

)

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Financing activities:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Taxes paid related to net settlement of equity awards

Ìý

Ìý

(1,070

)

Ìý

Ìý

(855

)

Payment of cash dividends

Ìý

Ìý

(943

)

Ìý

Ìý

(849

)

Net cash used in financing activities

Ìý

Ìý

(2,013

)

Ìý

Ìý

(1,704

)

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Effect of exchange rate changes on cash and cash equivalents

Ìý

Ìý

7

Ìý

Ìý

Ìý

(40

)

Net increase in cash and cash equivalents

Ìý

Ìý

17,820

Ìý

Ìý

Ìý

12,074

Ìý

Cash and cash equivalents at beginning of period

Ìý

Ìý

59,469

Ìý

Ìý

Ìý

40,333

Ìý

Cash and cash equivalents at end of period

Ìý

$

77,289

Ìý

Ìý

$

52,407

Ìý

Reconciliation of GAAP to Non-GAAP Financial Measures(1)

Operating Results Summary

(In thousands)

(Unaudited)

Ìý

Ìý

Ìý

Three Months Ended March 31,

Ìý

Ìý

Ìý

2025

Ìý

Ìý

2024

Ìý

GAAP net income

Ìý

$

4,332

Ìý

Ìý

$

5,227

Ìý

Interest income

Ìý

Ìý

(931

)

Ìý

Ìý

(904

)

Interest expense

Ìý

Ìý

25

Ìý

Ìý

Ìý

24

Ìý

Income tax provision

Ìý

Ìý

916

Ìý

Ìý

Ìý

1,316

Ìý

Stock-based compensation expense

Ìý

Ìý

1,104

Ìý

Ìý

Ìý

1,060

Ìý

Depreciation and amortization

Ìý

Ìý

10,755

Ìý

Ìý

Ìý

10,336

Ìý

Adjusted EBITDA

Ìý

$

16,201

Ìý

Ìý

$

17,059

Ìý

Ìý

(1) This press release presents adjusted EBITDA, which is a non-GAAP financial measure used by management in analyzing its financial results and ongoing operational performance.

Reconciliation of GAAP to Non-GAAP Financial Measures

Financial Outlook for 2025

(In thousands)

(Unaudited)

Ìý

Ìý

Ìý

Low

Ìý

Ìý

High

Ìý

Net income

Ìý

$

18,600

Ìý

Ìý

$

21,000

Ìý

Interest income

Ìý

Ìý

(3,100

)

Ìý

Ìý

(3,500

)

Interest expense

Ìý

Ìý

100

Ìý

Ìý

Ìý

100

Ìý

Income tax provision

Ìý

Ìý

4,900

Ìý

Ìý

Ìý

5,700

Ìý

Stock-based compensation expense

Ìý

Ìý

4,300

Ìý

Ìý

Ìý

4,900

Ìý

Depreciation and amortization

Ìý

Ìý

43,700

Ìý

Ìý

Ìý

44,300

Ìý

Adjusted EBITDA

Ìý

$

68,500

Ìý

Ìý

$

72,500

Ìý

This press release includes certain forward-looking statements (statements other than solely with respect to historical fact), including statements regarding expectations for financial performance for 2025 and our quarterly dividend policy, that involve risks and uncertainties regarding HealthStream. These statements are based upon management’s beliefs, as well as assumptions made by and data currently available to management. This information has been, or in the future may be, included in reliance on the “safe harbor� provisions of the Private Securities Litigation Reform Act of 1995. The Company cautions that forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements to be materially different from future results, performance, or achievements expressed or implied by the forward-looking statements, including as a result of negative economic conditions, changes in U.S. policy, adverse developments impacting the healthcare industry, tariff and trade-related developments, inflationary pressures, geopolitical instability, legal requirements and contractual restrictions which may affect continuation of our quarterly cash dividend policy and the declaration and/or payment of dividends thereunder, which may be modified, suspended, or canceled in any manner and at any time that our Board may deem necessary or appropriate, as well as risks referenced in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, filed on February 28, 2025, and in the Company’s other filings with the Securities and Exchange Commission from time to time. Consequently, such forward-looking information should not be regarded as a representation or warranty or statement by the Company that such projections will be realized. Many of the factors that will determine the Company’s future results are beyond the ability of the Company to control or predict. Readers should not place undue reliance on forward-looking statements, which reflect management’s views only as of the date hereof. The Company undertakes no obligation to update or revise any such forward-looking statements.

Scott A. Roberts

Chief Financial Officer

(615) 301-3182

[email protected]

Media:

Mollie Condra, Ph.D.

Head, Investor Relations & Communications

(615) 301-3237

[email protected]

Source: HealthStream, Inc.

Healthstream

NASDAQ:HSTM

HSTM Rankings

HSTM Latest News

HSTM Latest SEC Filings

HSTM Stock Data

782.97M
24.18M
20.56%
76.42%
2.1%
Health Information Services
Services-computer Programming, Data Processing, Etc.
United States
NASHVILLE